Hyundai, Takeda team up for TachoSil patch

Published: 2012-10-26 06:56:00

Updated: 2012-10-26 06:56:00

Hyundai Pharm announced Wednesday that it has signed an agreement with Takeda Pharmaceuticals Korea for the exclusive distribution right in Korea of TachoSil (absorbable fibrin sealant patch) for use as an adjunct to hemostasis in cardiovascular surgery.

In addition to Tachocomb patch, the enhanced product lineups will allow Hyundai to strengthen its presence in the domestic hemostasis marke...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.